Hospital, Libourne, France Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2010
NCT01066559
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

CH Libourne

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 3